FactSet Research Systems Inc. (FDS)

FairStock Score: 62/100 — STEADY

Key Financials

Strengths

• Subscription-based recurring revenue model with high switching costs in professional financial services
• Exceptional profitability: 25.11% net margin, 28.83% ROE, and $545.5M annual free cash flow
• Defensible market position serving institutional investors with mission-critical data and analytics tools
• Stable, predictable business model less vulnerable to economic cycles than transactional services
• Solid financial health: Altman Z-Score of 3.59 indicates low bankruptcy risk

Concerns

• Valuation significantly divorced from intrinsic value: price 3x Graham Number with negative margin of safety
• Extremely elevated EV/EBITDA multiple of 37.38x leaves minimal room for error or disappointment
• Piotroski F-Score of 7/9 suggests deteriorating financial statement quality—warrant further investigation
• Rising competitive and disruption threats from fintech, alternative data providers, and cost-conscious platforms
• FCF yield of only 1.1% inadequate to justify premium valuation absent accelerating growth

AI Analysis

FactSet presents an interesting paradox—a genuinely high-quality business trading at a price that demands extreme caution. Let me be direct: at $221 against a Graham Number of $73, we're looking at a 202% margin of safety in reverse. This isn't merely expensive; it's dangerous. That said, the business itself merits respect. FactSet operates a subscription-based financial data platform with genuine switching costs—institutional investors depend on their terminals and analytics the way surgeons depend on their instruments. The 28.83% ROE and 25% net margins in Q4 2025 reflect pricing power and operational excellence. Free cash flow of $545.5M annually demonstrates the business generates real, tangible returns. Yet valuation cannot be ignored. At 37.38x EV/EBITDA, the market is pricing in perfection. The 1.1% FCF yield is anemic for any business, regardless of quality. The Piotroski F-Score of 7/9 suggests some deterioration in financial health metrics—worth investigating. Meanwhile, the beta of 0.75 indicates investors are treating this as defensive, which makes the premium pricing even more difficult to justify. The company faces real headwinds: fintech disruption, regulatory pressure on data costs, and competition from Bloomberg and lower-cost alternatives. With 12,886 employees, there's considerable cost structure to manage through any cyclical downturn. My conclusion? FactSet is a Rolls-Royce of a business, but it's priced like a Bugatti. I'd rather wait for a 40% market correction or a deterioration in fundamentals before committing capital here. Quality alone doesn't overcome valuation excess.

Bull Case

FactSet's moat is deeper than most realize—institutional workflows lock in clients for decades, enabling sustained pricing power and 25%+ margins. As markets grow and regulation increases, demand for specialized data infrastructure should compound, justifying premium valuations if the company can maintain growth momentum.

Bear Case

A 40% market correction or any hint of margin compression would devastate this valuation, given the elevated EV/EBITDA multiple. Disruption from cheaper, cloud-native alternatives and potential regulation of data monopolies could structurally compress returns, making current prices a value trap for patient investors.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer